The pivotal GLP-1 trials the ones generating the headline weight loss numbers were run mostly in younger, premenopausal participants
High training loads the long runs, the back-to-back training, the caloric demands can quietly disrupt your hormonal signaling, throw off your cycle, destabilize your mood, and leave your body running suboptimally
Meanwhile, Geoff Cook, Nooms CEO, noted that selling this product would not interfere with any current regulations, commenting to Reuters that there is a personalized, and there has always been a personalized, exception. Especially as of late, the sale of weight loss drugs by telehealth companies has been a trend
If so, add it to the comment box before clicking Vote. Well share the suggested answers in a future newsletter
Decisions regarding oral GLP-1 pills could redefine treatment standards across the country